Get started
Author

Kazuteru Mitsuhashi

Testosterone stimulates glucose uptake and GLUT4 translocation through LKB1/AMPK signaling in 3T3-L1 adipocytes
2015 · Kazuteru Mitsuhashi, Takafumi Senmaru, et al. · Endocrine · 56
Transient remission of nonalcoholic fatty liver disease decreases the risk of incident type 2 diabetes mellitus in Japanese men
2016 · Takuya Fukuda, Masahide Hamaguchi, et al. · European Journal of Gastroenterology & Hepatology · 42
Erratum to: Testosterone stimulates glucose uptake and GLUT4 translocation through LKB1/AMPK signaling in 3T3-L1 adipocytes
2016 · Kazuteru Mitsuhashi, Takafumi Senmaru, et al. · Endocrine · 40
PDF
The inter-arm difference in systolic blood pressure is a novel risk marker for subclinical atherosclerosis in patients with type 2 diabetes
2014 · Yoshimitsu Tanaka, Michiaki Fukui, et al. · Hypertension Research · 39
PDF
Effect of repaglinide versus glimepiride on daily blood glucose variability and changes in blood inflammatory and oxidative stress markers
2014 · Masahiro Yamazaki, Goji Hasegawa, et al. · Diabetology & Metabolic Syndrome · 32
PDF
Combined effect of body mass index and waist-height ratio on incident diabetes; a population based cohort study
2017 · Kazuteru Mitsuhashi, Yoshitaka Hashimoto, et al. · Journal of Clinical Biochemistry and Nutrition · 27
PDF
Abnormal lipid/lipoprotein metabolism and high plasma testosterone levels in male but not female aromatase-knockout mice
2017 · Akiko Amano, Yoshitaka Kondo, et al. · Archives of Biochemistry and Biophysics · 25
Is home blood pressure reporting in patients with type 2 diabetes reliable?
2014 · Shinobu Matsumoto, Michiaki Fukui, et al. · Hypertension Research · 18
PDF
Impact of fatty liver disease and metabolic syndrome on incident type 2 diabetes; a population based cohort study
2017 · Kazuteru Mitsuhashi, Yoshitaka Hashimoto, et al. · Endocrine Journal · 15
PDF
Home Blood Pressure Variability From the Stored Memory Is Correlated With Albuminuria, but From the Logbook Is not
2017 · Shinobu Matsumoto, Emi Ushigome, et al. · American Journal of Hypertension · 8
Multicenter, Open-Label, 2-Arm, Pilot Trial for Safe Reduction of Basal Insulin Dose Combined with SGLT2 Inhibitor in Type 1 Diabetes Mellitus: Study Protocol for a RISING-STAR Trial
2021 · Masahide Hamaguchi, Yoshitaka Hashimoto, et al. · Clinical Medicine Insights Endocrinology and Diabetes · 4
PDF
Multicenter, open label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP ‐ STAR study
2024 · Hanako Nakajima, Hiroshi Okada, et al. · Journal of Diabetes Investigation · 3
PDF
Multicenter, Open Label, Randomized Controlled Superiority Trial for Availability to Reduce Nocturnal Urination Frequency: Study Protocol for a TOP-STAR Study
2022 · Hanako Nakajima, Hiroshi Okada, et al. · Diabetology · 3
PDF
Insulin dose reduction in dapagliflozin combination therapy for type 1 diabetes mellitus: the RISING-STAR study
2022 · Masahide Hamaguchi, Yuta Yoshimura, et al. · Journal of Clinical Biochemistry and Nutrition · 3
PDF
Non-inferiority of sodium zirconium cyclosilicate versus potassium-restricted diet in achieving normokalaemia in patients with type 2 diabetes mellitus: protocol for a multicentre, open-label, randomised controlled, two-arm clinical trial (SILVERSTAR study)
2025 · Junya Hironaka, Hiroshi Okada, et al. · BMJ Open · 2
Clinical Characteristics of Patients Who Report Incorrect Data of Home-Measured Blood Pressure
2014 · Shinobu Matsumoto, Michiaki Fukui, et al. · Diabetes Care · 2
944-P: Impact of Salt Reduction on Nocturia in Patients with Type 2 Diabetes—The TOP-STAR Study
2024 · YUTO SAIJO, HIROSHI OKADA, et al. · Diabetes · 1
Younger patients and low c‐peptide immunoreactivity index but not nutritional states affect fasting blood ketone levels in Japanese with type 1 diabetes after sodium‐glucose cotransporter 2 inhibitor administration
2023 · Hanako Nakajima, Hiroshi Okada, et al. · Diabetes Obesity and Metabolism
134-LB: Efficacy and Safety of Dapagliflozin in Type 1 Diabetes: The RISING-STAR Study
2021 · MASAHIDE HAMAGUCHI, MASAHIRO YAMAZAKI, et al. · Diabetes
Multicenter, open-label, two-arm, pilot trial for safe reduction of basal insulin dose combined with SGLT2 inhibitor in type 1 diabetes mellitus: study protocol for a RISING-STAR trial.
2021 · Masahide Hamaguchi, Yoshitaka Hashimoto, et al. · Research Square
PDF
Multicenter, open-label, two-arm pilot trial for safety reduction of basal insulin dose combined with SGLT2 inhibitor in type 1 diabetes mellitus: A study protocol for RISING-STAR
2020 · Masahide Hamaguchi, Yoshitaka Hashimoto, et al. · Research Square
PDF
Multicenter, Open-Label, Two-Arm, Pilot Trial for Safety Reduction of Basal Insulin Dose Combined with SGLT2 Inhibitor in Type 1 Diabetes Mellitus: Study Protocol for RISING-STAR.
2020 · Masahide Hamaguchi, Yoshitaka Hashimoto, et al. · Research Square
PDF
[Drug-induced diabetes mellitus].
2012 · Kazuteru Mitsuhashi, Saori Majima, et al. · PubMed
Works count: 23
Citation count: 320
H-index: 9
I10-index: 9
Year
Topic
Type